Cord blood therapy offers hope for long COVID sufferers
Disease control
AVAILABLE
This expanded access program offers REGENECYTE, a human umbilical cord blood infusion, to adults with Long COVID who are not eligible for other clinical trials. The goal is to manage ongoing symptoms like chronic fatigue. Participants must have a recent negative COVID-19 test and…
Sponsor: StemCyte, Inc. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC